ICU Medical, Inc. ICUI NASDAQ

ICU Medical, Inc. (ICUI) generated $179.85M in operating cash flow for fiscal year 2025. After capital expenditures of $88.04M, free cash flow was $91.8M.

Free cash flow margin was 4.1% of revenue. Cash conversion ratio was 245.69x, indicating earnings are backed by cash.

The company returned $8.77M in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (60/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (30/100) — Cash conversion ratio was 245.69x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 44/100 with 1/7 criteria passed.